<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Statin Intensity Selector ‚Äì Cardiology</title>
  <style>
    :root {
      --bg: #020617;
      --card: #0b1120;
      --accent: #f97316;
      --accent-soft: rgba(249,115,22,0.16);
      --muted: #9ca3af;
      --border: rgba(148,163,184,0.35);
      --radius: 16px;
      --pad: 14px;
      color-scheme: dark;
    }
    * { box-sizing: border-box; }
    body {
      margin: 0;
      min-height: 100vh;
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background:
        radial-gradient(circle at top, rgba(248,113,22,0.22), transparent 50%),
        radial-gradient(circle at bottom, #020617, #020617 55%);
      color: #e5e7eb;
      display: flex;
      justify-content: center;
      padding: 14px;
    }
    main {
      width: 100%;
      max-width: 980px;
    }
    header {
      margin-bottom: 14px;
    }
    h1 {
      font-size: 1.6rem;
      margin: 0 0 4px;
      display: flex;
      align-items: center;
      gap: 10px;
    }
    h1 .icon {
      font-size: 1.6rem;
    }
    header p {
      margin: 0;
      font-size: 0.85rem;
      color: var(--muted);
    }
    .tag-row {
      display: flex;
      flex-wrap: wrap;
      gap: 6px;
      margin-top: 6px;
    }
    .tag {
      font-size: 0.75rem;
      padding: 3px 7px;
      border-radius: 999px;
      border: 1px solid rgba(148,163,184,0.5);
      color: var(--muted);
      background: rgba(15,23,42,0.9);
    }
    .layout {
      display: grid;
      gap: 14px;
    }
    @media (min-width: 880px) {
      .layout {
        grid-template-columns: minmax(0, 1.2fr) minmax(0, 1fr);
      }
    }
    .card {
      background: linear-gradient(135deg, rgba(15,23,42,0.96), rgba(15,23,42,0.99));
      border-radius: var(--radius);
      border: 1px solid var(--border);
      padding: var(--pad);
      box-shadow: 0 18px 40px rgba(0,0,0,0.75);
      position: relative;
      overflow: hidden;
    }
    .card::before {
      content: "";
      position: absolute;
      inset: -45%;
      background:
        radial-gradient(circle at 0 0, rgba(248,113,113,0.16), transparent 55%),
        radial-gradient(circle at 100% 100%, rgba(249,115,22,0.22), transparent 55%);
      opacity: 0.7;
      pointer-events: none;
    }
    .card-inner {
      position: relative;
      z-index: 1;
    }
    .card h2 {
      margin: 0 0 4px;
      font-size: 1.1rem;
      display: flex;
      align-items: center;
      justify-content: space-between;
      gap: 6px;
    }
    .badge {
      font-size: 0.7rem;
      text-transform: uppercase;
      letter-spacing: 0.08em;
      padding: 3px 7px;
      border-radius: 999px;
      background: var(--accent-soft);
      color: #fed7aa;
      border: 1px solid rgba(248,250,252,0.08);
      white-space: nowrap;
    }
    .subtitle {
      margin: 0 0 8px;
      font-size: 0.8rem;
      color: var(--muted);
    }
    form {
      display: grid;
      gap: 8px;
    }
    .field {
      display: flex;
      flex-direction: column;
      font-size: 0.82rem;
    }
    label {
      font-size: 0.8rem;
    }
    input[type="number"], select {
      margin-top: 2px;
      padding: 6px 8px;
      border-radius: 9px;
      border: 1px solid rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.9);
      color: #e5e7eb;
      font-size: 0.85rem;
    }
    .checkbox-group {
      display: grid;
      gap: 4px;
      font-size: 0.8rem;
      margin-top: 4px;
    }
    .helper {
      font-size: 0.72rem;
      color: var(--muted);
      margin-top: 2px;
    }
    .btn-row {
      margin-top: 6px;
      display: flex;
      gap: 8px;
      flex-wrap: wrap;
    }
    button {
      border-radius: 999px;
      border: none;
      padding: 7px 13px;
      font-size: 0.85rem;
      font-weight: 500;
      cursor: pointer;
      background: radial-gradient(circle at 0 0, #fed7aa, #fb923c 40%, #ea580c 100%);
      color: #111827;
      box-shadow: 0 10px 26px rgba(248,113,22,0.55);
      display: inline-flex;
      align-items: center;
      gap: 6px;
      transition: transform 0.08s ease, box-shadow 0.08s ease, filter 0.08s ease;
    }
    button:hover {
      transform: translateY(-1px);
      filter: brightness(1.05);
      box-shadow: 0 14px 32px rgba(248,113,22,0.7);
    }
    button.secondary {
      background: transparent;
      color: #e5e7eb;
      border: 1px solid rgba(148,163,184,0.6);
      box-shadow: none;
    }
    .result {
      font-size: 0.82rem;
      display: grid;
      gap: 8px;
    }
    .result-block {
      padding: 8px 9px;
      border-radius: 10px;
      background: rgba(15,23,42,0.9);
      border: 1px solid rgba(148,163,184,0.45);
    }
    .result-title {
      font-weight: 600;
      margin-bottom: 2px;
      font-size: 0.86rem;
    }
    .highlight {
      font-weight: 600;
      color: #fed7aa;
    }
    .pill-row {
      display: flex;
      flex-wrap: wrap;
      gap: 4px;
      margin-top: 4px;
    }
    .pill {
      font-size: 0.72rem;
      padding: 2px 6px;
      border-radius: 999px;
      border: 1px solid rgba(148,163,184,0.45);
      color: #e5e7eb;
    }
    .section-title {
      font-size: 0.78rem;
      text-transform: uppercase;
      letter-spacing: 0.08em;
      color: var(--muted);
      margin-bottom: 4px;
    }
    .intensity-high { color: #f97373; }
    .intensity-moderate { color: #facc15; }
    .intensity-low { color: #4ade80; }
    footer {
      margin-top: 12px;
      font-size: 0.72rem;
      color: var(--muted);
    }
  </style>
</head>
<body>
  <main>
    <header>
      <h1><span class="icon">üíä</span> Statin Intensity Selector</h1>
      <p>Suggests high, moderate, or low-intensity statin therapy with example agents & doses, based on basic clinical inputs.</p>
      <div class="tag-row">
        <span class="tag">Cardiology theme</span>
        <span class="tag">ACC/AHA-style logic</span>
        <span class="tag">Educational decision support</span>
      </div>
    </header>

    <section class="layout">
      <!-- Input side -->
      <article class="card">
        <div class="card-inner">
          <h2>
            Patient & Risk Profile
            <span class="badge">Inputs</span>
          </h2>
          <p class="subtitle">Fill what you know; unknown fields can stay blank or ‚ÄúNot sure‚Äù.</p>

          <form id="statin-form">
            <div class="field">
              <label for="age">Age (years)</label>
              <input id="age" type="number" min="16" max="100" value="60">
            </div>

            <div class="field">
              <label for="sex">Sex</label>
              <select id="sex">
                <option value="M">Male</option>
                <option value="F">Female</option>
                <option value="O">Other / not specified</option>
              </select>
            </div>

            <div class="field">
              <label for="ldl">LDL-C (mg/dL)</label>
              <input id="ldl" type="number" min="20" max="400" placeholder="e.g. 145">
              <div class="helper">If unknown, leave blank.</div>
            </div>

            <div class="field">
              <label for="scenario">Clinical scenario</label>
              <select id="scenario">
                <option value="secondary">Clinical ASCVD (secondary prevention)</option>
                <option value="primary">No known ASCVD (primary prevention)</option>
              </select>
            </div>

            <div class="field">
              <label>Key conditions</label>
              <div class="checkbox-group">
                <label><input type="checkbox" id="diabetes"> Diabetes (esp. age 40‚Äì75)</label>
                <label><input type="checkbox" id="very-high-ldl"> Known LDL ‚â•190 mg/dL or familial hypercholesterolemia</label>
                <label><input type="checkbox" id="ckd"> CKD (eGFR &lt;60 but not dialysis/transplant)</label>
              </div>
            </div>

            <div class="field">
              <label for="risk-category">10-year ASCVD risk (if primary)</label>
              <select id="risk-category">
                <option value="unknown">Not sure / not calculated</option>
                <option value="low">&lt;5% (low)</option>
                <option value="borderline">5‚Äì7.4% (borderline)</option>
                <option value="intermediate">7.5‚Äì19.9% (intermediate)</option>
                <option value="high">‚â•20% (high)</option>
              </select>
              <div class="helper">Use the separate ASCVD tool if you want to calculate this precisely.</div>
            </div>

            <div class="field">
              <label>Additional risk enhancers</label>
              <div class="checkbox-group">
                <label><input type="checkbox" id="risk-enhancers">
                  Multiple risk enhancers (premature ASCVD FHx, high hs-CRP, ABI &lt;0.9, persistently high LDL, etc.)
                </label>
              </div>
            </div>

            <div class="field">
              <label>Contraindications / caution</label>
              <div class="checkbox-group">
                <label><input type="checkbox" id="pregnancy"> Pregnancy or trying to conceive</label>
                <label><input type="checkbox" id="active-liver"> Active liver disease / very high LFTs</label>
                <label><input type="checkbox" id="intolerance"> Prior statin intolerance / myopathy</label>
                <label><input type="checkbox" id="dialysis"> Dialysis or kidney transplant</label>
              </div>
            </div>

            <div class="btn-row">
              <button type="submit">
                <span>Suggest statin intensity</span>
              </button>
              <button type="button" class="secondary" id="reset-btn">Reset</button>
            </div>
          </form>
        </div>
      </article>

      <!-- Output side -->
      <article class="card">
        <div class="card-inner">
          <h2>
            Suggested Strategy
            <span class="badge">Output</span>
          </h2>
          <p class="subtitle">Intensity, example agents & doses, and monitoring notes.</p>

          <div id="result" class="result">
            <div class="result-block">
              <div class="result-title">Start by entering patient details.</div>
              <div>Then click <span class="highlight">‚ÄúSuggest statin intensity‚Äù</span> to see recommendations.</div>
            </div>
          </div>
        </div>
      </article>
    </section>

    <footer>
      Educational support only ‚Äì not a substitute for clinical judgement. Confirm with latest lipid guidelines, patient preferences, and local protocols.
    </footer>
  </main>

  <script>
    function buildScenarioSummary(age, sex, scenario, diabetes, veryHighLDL, riskCat) {
      const parts = [];
      if (!isNaN(age) && age > 0) parts.push("Age " + age);
      if (sex === "M") parts.push("male");
      else if (sex === "F") parts.push("female");

      if (scenario === "secondary") {
        parts.push("with clinical ASCVD");
      } else {
        parts.push("without known ASCVD");
      }
      if (diabetes) parts.push("with diabetes");
      if (veryHighLDL) parts.push("LDL ‚â•190 / severe hypercholesterolemia");

      if (scenario === "primary" && riskCat && riskCat !== "unknown") {
        const labelMap = {
          low: "low 10-yr risk (<5%)",
          borderline: "borderline 10-yr risk (5‚Äì7.4%)",
          intermediate: "intermediate 10-yr risk (7.5‚Äì19.9%)",
          high: "high 10-yr risk (‚â•20%)"
        };
        parts.push(labelMap[riskCat]);
      }

      return parts.length ? parts.join(", ") : "Profile not fully specified";
    }

    function computeIntensity(inputs) {
      const {
        age,
        scenario,
        diabetes,
        veryHighLDL,
        ldl,
        riskCat,
        riskEnhancers,
        pregnancy,
        activeLiver,
        intolerance,
        dialysis
      } = inputs;

      // Contraindications
      if (pregnancy || activeLiver) {
        return {
          level: "contra",
          title: "Statins generally contraindicated",
          classText: "Avoid routine statin therapy",
          explanation: "Pregnancy and active, significant liver disease are classic situations where statins are usually avoided. Involve cardiology/obstetrics/hepatology for alternative lipid strategies.",
          notes: [
            "Defer statin therapy until after pregnancy/breastfeeding or liver disease is stabilized.",
            "If ASCVD risk is very high, consider specialist input on non-statin options."
          ]
        };
      }

      // Starting from here, we choose intensity
      // Secondary prevention (clinical ASCVD)
      if (scenario === "secondary") {
        // Age & very high LDL can tilt to high-intensity
        if (age <= 75 || veryHighLDL || riskCat === "high" || riskEnhancers) {
          return {
            level: "high",
            title: "Secondary prevention ‚Äì high-intensity preferred",
            classText: "High-intensity statin recommended if tolerated",
            explanation: "Clinical ASCVD typically calls for high-intensity statin therapy unless contraindicated or not tolerated.",
            notes: [
              "Aim for ‚â•50% LDL-C reduction and LDL-C <70 mg/dL in very high-risk patients.",
              "If LDL-C remains ‚â•70 mg/dL on maximally tolerated statin, consider adding ezetimibe or PCSK9 inhibitor per guidelines."
            ]
          };
        } else {
          return {
            level: "moderate",
            title: "Secondary prevention ‚Äì at least moderate-intensity",
            classText: "Moderate- to high-intensity statin reasonable",
            explanation: "In older or frailer patients with ASCVD, moderate-intensity statin may be appropriate, with shared decision making about higher doses.",
            notes: [
              "Aim for substantial LDL-C lowering while balancing frailty, polypharmacy, and adverse effects.",
              "Discuss potential benefits vs side effects and re-evaluate regularly."
            ]
          };
        }
      }

      // Primary prevention, LDL ‚â•190 or severe hypercholesterolemia
      if (veryHighLDL || (!isNaN(ldl) && ldl >= 190)) {
        return {
          level: "high",
          title: "Severe primary hypercholesterolemia",
          classText: "High-intensity statin generally recommended",
          explanation: "LDL-C ‚â•190 mg/dL (or familial hypercholesterolemia) usually warrants high-intensity statin regardless of calculated 10-year risk.",
          notes: [
            "Aim for ‚â•50% LDL-C reduction.",
            "Consider adding ezetimibe or other agents if LDL-C remains high despite maximal statin therapy."
          ]
        };
      }

      // Diabetes, age 40‚Äì75, LDL 70‚Äì189, no ASCVD
      if (diabetes && age >= 40 && age <= 75 && (isNaN(ldl) || (ldl >= 70 && ldl < 190))) {
        if (riskCat === "high" || riskEnhancers) {
          return {
            level: "high",
            title: "Diabetes (40‚Äì75) with higher overall risk",
            classText: "High-intensity statin reasonable",
            explanation: "In diabetics with multiple risk factors or high estimated 10-year risk, a high-intensity statin is often chosen.",
            notes: [
              "Aim for ‚â•50% LDL-C reduction.",
              "Review for CKD, albuminuria, long duration of diabetes, or other enhancers that support high-intensity therapy."
            ]
          };
        } else {
          return {
            level: "moderate",
            title: "Diabetes (40‚Äì75) without clear high-risk features",
            classText: "Moderate-intensity statin usually recommended",
            explanation: "Most adults aged 40‚Äì75 with diabetes and LDL-C 70‚Äì189 mg/dL are treated with at least a moderate-intensity statin.",
            notes: [
              "Consider escalation to high-intensity if additional risk enhancers or higher ASCVD risk are identified.",
              "Lifestyle interventions remain important alongside statin therapy."
            ]
          };
        }
      }

      // Primary prevention without diabetes or ASCVD, age 40‚Äì75, LDL 70‚Äì189
      if (!diabetes && scenario === "primary" && age >= 40 && age <= 75 && (isNaN(ldl) || (ldl >= 70 && ldl < 190))) {
        switch (riskCat) {
          case "low":
            return {
              level: "none-or-low",
              title: "Low 10-year ASCVD risk (<5%)",
              classText: "Emphasize lifestyle; statin usually not needed",
              explanation: "For low-risk primary prevention patients, aggressive lifestyle measures are first-line and statins are often not routinely used.",
              notes: [
                "Consider statin only if strong risk enhancers or very high LDL-C are present.",
                "Reassess risk every 4‚Äì6 years or sooner if clinical situation changes."
              ]
            };
          case "borderline":
            return {
              level: "borderline",
              title: "Borderline 10-year risk (5‚Äì7.4%)",
              classText: "Consider moderate-intensity statin if risk enhancers present",
              explanation: "In borderline risk, statin decisions depend heavily on risk enhancers and shared decision making.",
              notes: [
                "If risk enhancers present (family history of premature ASCVD, CKD, etc.), moderate-intensity statin is reasonable.",
                "If no risk enhancers, lifestyle alone may be reasonable."
              ]
            };
          case "intermediate":
            return {
              level: "moderate",
              title: "Intermediate 10-year risk (7.5‚Äì19.9%)",
              classText: "Moderate-intensity statin typically recommended",
              explanation: "Most intermediate-risk patients benefit from moderate-intensity statin therapy.",
              notes: [
                "Escalate to high-intensity if multiple risk enhancers or very high LDL-C.",
                "Coronary artery calcium (CAC) scoring may refine the decision in uncertain cases."
              ]
            };
          case "high":
            return {
              level: "high",
              title: "High 10-year risk (‚â•20%)",
              classText: "High-intensity statin generally recommended",
              explanation: "In high 10-year ASCVD risk, benefits of high-intensity statin typically outweigh risks.",
              notes: [
                "Aim for ‚â•50% LDL-C reduction.",
                "Monitor for myopathy, new-onset diabetes, and liver enzyme changes."
              ]
            };
          case "unknown":
          default:
            return {
              level: "moderate",
              title: "Primary prevention ‚Äì risk not quantified",
              classText: "Moderate-intensity statin may be reasonable",
              explanation: "Without a calculated 10-year risk, many adults with multiple risk factors are treated with at least a moderate-intensity statin.",
              notes: [
                "Consider calculating 10-year ASCVD risk or using CAC scoring for clarification.",
                "Lifestyle optimization is recommended in all risk groups."
              ]
            };
        }
      }

      // Age <40 or >75 primary prevention ‚Äì more individualized
      return {
        level: "individualized",
        title: "Individualized primary prevention decision",
        classText: "Statin choice should be individualized",
        explanation: "For patients outside the classic 40‚Äì75-year primary prevention range, statin therapy depends on risk factors, life expectancy, and patient preference.",
        notes: [
          "In younger patients with strong risk enhancers or very high LDL-C, moderate- or high-intensity statin can still be considered.",
          "In older adults, balance ASCVD benefit with comorbidity, frailty, and polypharmacy."
        ]
      };
    }

    function renderResult(summary, intensityInfo, intolerance, dialysis) {
      const container = document.getElementById("result");

      function intensityLine(info) {
        switch (info.level) {
          case "high": return `<span class="intensity-high">High-intensity statin suggested</span>`;
          case "moderate": return `<span class="intensity-moderate">Moderate-intensity statin suggested</span>`;
          case "low": return `<span class="intensity-low">Low-intensity statin suggested</span>`;
          case "none-or-low": return `<span class="intensity-low">Lifestyle focus; usually no statin or at most low-intensity</span>`;
          case "borderline": return `<span class="intensity-moderate">Consider moderate-intensity if risk enhancers</span>`;
          case "contra": return `<span class="intensity-high">Avoid routine statins ‚Äì contraindication</span>`;
          case "individualized": default: return `<span class="intensity-moderate">Individualized statin decision</span>`;
        }
      }

      const highExamples = `
        <div class="section-title">High-intensity examples (‚âà‚â•50% LDL reduction)</div>
        <ul>
          <li>Atorvastatin <strong>40‚Äì80 mg</strong> once daily</li>
          <li>Rosuvastatin <strong>20‚Äì40 mg</strong> once daily</li>
        </ul>
      `;
      const moderateExamples = `
        <div class="section-title">Moderate-intensity examples (‚âà30‚Äì49% LDL reduction)</div>
        <ul>
          <li>Atorvastatin <strong>10‚Äì20 mg</strong> once daily</li>
          <li>Rosuvastatin <strong>5‚Äì10 mg</strong> once daily</li>
          <li>Simvastatin <strong>20‚Äì40 mg</strong> once daily</li>
          <li>Pravastatin <strong>40‚Äì80 mg</strong> once daily</li>
          <li>Lovastatin <strong>40 mg</strong> once daily</li>
          <li>Pitavastatin <strong>2‚Äì4 mg</strong> once daily</li>
        </ul>
      `;
      const lowExamples = `
        <div class="section-title">Low-intensity examples (‚âà&lt;30% LDL reduction)</div>
        <ul>
          <li>Simvastatin <strong>10 mg</strong> once daily</li>
          <li>Pravastatin <strong>10‚Äì20 mg</strong> once daily</li>
          <li>Lovastatin <strong>20 mg</strong> once daily</li>
          <li>Pitavastatin <strong>1 mg</strong> once daily</li>
        </ul>
      `;

      const intoleranceNote = intolerance
        ? `<div class="result-block">
             <div class="result-title">Statin intolerance / myopathy history</div>
             <div>Use the <strong>maximally tolerated dose</strong>, consider alternate-day dosing or switching agent (e.g., pravastatin or rosuvastatin), and evaluate for secondary causes (hypothyroidism, drug interactions, etc.).</div>
           </div>`
        : "";

      const dialysisNote = dialysis
        ? `<div class="result-block">
             <div class="result-title">Dialysis / transplant caution</div>
             <div>In dialysis or post-transplant patients, the net benefit of initiating or intensifying statins is less clear. Follow renal and transplant-specific guidelines and involve nephrology.</div>
           </div>`
        : "";

      container.innerHTML = `
        <div class="result-block">
          <div class="result-title">Clinical summary</div>
          <div>${summary}</div>
        </div>

        <div class="result-block">
          <div class="result-title">Suggested statin strategy</div>
          <div>${intensityLine(intensityInfo)}</div>
          <div style="margin-top:4px;">${intensityInfo.explanation}</div>
          <div class="pill-row">
            <span class="pill">${intensityInfo.title}</span>
          </div>
        </div>

        <div class="result-block">
          <div class="result-title">Example regimens (adjust to patient & renal function)</div>
          ${intensityInfo.level === "high" ? highExamples + moderateExamples : ""}
          ${intensityInfo.level === "moderate" || intensityInfo.level === "borderline" || intensityInfo.level === "individualized" || intensityInfo.level === "none-or-low"
            ? moderateExamples + lowExamples
            : ""}
          ${intensityInfo.level === "contra" ? "" : ""}
        </div>

        <div class="result-block">
          <div class="result-title">Monitoring & follow-up</div>
          <ul>
            <li>Check fasting lipid panel at baseline and 4‚Äì12 weeks after starting or changing dose, then every 3‚Äì12 months.</li>
            <li>Assess for muscle symptoms; check CK only if clinically indicated.</li>
            <li>Baseline liver enzymes are reasonable; repeat if symptoms suggest hepatotoxicity.</li>
            <li>Reinforce lifestyle: diet, exercise, weight, tobacco cessation.</li>
          </ul>
        </div>

        ${intoleranceNote}
        ${dialysisNote}

        ${intensityInfo.notes && intensityInfo.notes.length
          ? `<div class="result-block">
               <div class="result-title">Additional notes</div>
               <ul>${intensityInfo.notes.map(n => `<li>${n}</li>`).join("")}</ul>
             </div>`
          : ""}
      `;
    }

    document.getElementById("statin-form").addEventListener("submit", function (e) {
      e.preventDefault();

      const age = Number(document.getElementById("age").value || 0);
      const sex = document.getElementById("sex").value;
      const ldl = Number(document.getElementById("ldl").value || NaN);
      const scenario = document.getElementById("scenario").value;
      const diabetes = document.getElementById("diabetes").checked;
      const veryHighLDL = document.getElementById("very-high-ldl").checked;
      const riskCat = document.getElementById("risk-category").value;
      const riskEnhancers = document.getElementById("risk-enhancers").checked;
      const pregnancy = document.getElementById("pregnancy").checked;
      const activeLiver = document.getElementById("active-liver").checked;
      const intolerance = document.getElementById("intolerance").checked;
      const dialysis = document.getElementById("dialysis").checked;

      const summary = buildScenarioSummary(age, sex, scenario, diabetes, veryHighLDL, riskCat);
      const intensityInfo = computeIntensity({
        age,
        scenario,
        diabetes,
        veryHighLDL,
        ldl,
        riskCat,
        riskEnhancers,
        pregnancy,
        activeLiver,
        intolerance,
        dialysis
      });

      renderResult(summary, intensityInfo, intolerance, dialysis);
    });

    document.getElementById("reset-btn").addEventListener("click", function () {
      document.getElementById("statin-form").reset();
      document.getElementById("risk-category").value = "unknown";
      document.getElementById("sex").value = "M";
      document.getElementById("scenario").value = "secondary";
      document.getElementById("age").value = "60";
      document.getElementById("result").innerHTML = `
        <div class="result-block">
          <div class="result-title">Start by entering patient details.</div>
          <div>Then click <span class="highlight">‚ÄúSuggest statin intensity‚Äù</span> to see recommendations.</div>
        </div>
      `;
    });
  </script>
</body>
</html>
